Target organ damage: Use of pulse wave analysis as a manifestation of aortic degeneration in the assessment of hypertension

Vascular Medicine

Volumn 7, Issue 2, 2002, Pages 83-85

  O'Rourke, Michael ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; VASODILATOR AGENT;

AORTA ATHEROSCLEROSIS; AORTA DISEASE; ARTERIOSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DRUG COST; EDITORIAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PULSE WAVE; SIDE EFFECT; SPHYGMOMANOMETRY; SURVIVAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TARGET ORGAN; WAVEFORM;

AORTA; BLOOD FLOW VELOCITY; HUMANS; HYPERTENSION; MULTIPLE ORGAN FAILURE; PULSE; RISK FACTORS; SYSTOLE; UNITED STATES;

EID: 0036402202     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x02vm419ed     Document Type: Editorial

References (28)

1. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
2. Chobanian AV. Control of hypertension - an important national priority [Editoria]. N Engl J Med 2001; 345: 534-35.
3. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-97.
4. Panza JA. High-normal blood pressure - more 'high' than 'normal' [Editorial]. N Engl J Med 2001; 345: 1337-40.
5. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83.
6. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-47.
7. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-15.
8. Nichols WW, O'Rourke MF (eds). McDonald's blood flow in arteries, 4th edition. London: Arnold, 1997.
9. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens 1996; 14 (suppl 5): S147-57.
10. O'Rourke MF. Vascular mechanisms in the clinic. J Biomech 2002 (in press).
11. Messerli F, Ventura H, Amodeo C. Osler's maneuver and pseudohypertension. N Engl J Med 1985; 13: 1548-51.
12. Blacher J, Asmar R, Djane S, London G, Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-17.
13. Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-39.
14. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-38.
15. Saba PS, Roman MJ, Pini R et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22: 1873-80.
16. Asmar RG, London GM, O'Rourke MF, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38: 922-926.
17. Bright R. Reports of medical cases selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. London: Longmans, 1827.
18. Broadbent WH. The pulse: its diagnostic, prognostic and therapeutic indications. Lancet 1875; ii: 441-43, 549-50, 583-85, 901-907.
19. Marey EJ. Physiologie medicale de la circulation du sang. Paris: Adrien Dellahaye, 1863.
20. O'Rourke MF. Frederick Akbar Mahomed: historical perspective. Hypertension 1992; 19: 212-17.
21. Mackenzie J. The study of the pulse: arterial, venous and hepatic, and of the movements of the heart. Edinburgh: Young J Pentland, 1902.
22. Osler W. The principles and practice of medicine, 3rd edition. Edinburgh: Young J Pentland, 1898.
23. Postel-Vinay N. A century of arterial hypertension 1896-1996. Chichester: Wiley, 1996.
24. O'Rourke MF, Vlachopoulos C, Graham R. Spurious systolic hypertension in youth. Vasc Med 2000; 5: 141-45.
25. Mahmud A, Feely J. Pseudo-systolic hypertension in young men - elastic not stiff arteries. J Hypertens 2001; (suppl 2): S115.
26. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. The relation of blood pressure to coronary heart disease risk as a function of age: the Framingham Heart Study. J Am Coll Cardiol 2000; 35: 291A.
27. Safar ME, London GM, for the Clinical Committee of Arterial Structure and Function, on behald of the Working Group on Vascular Structure and Function of the European Society of Hypertension. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 2000; 18: 1527-35.
28. Safar ME. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised [Editorial]. Circulation 2001; 103: 1188-89.